Paula Cloghessy
Keine laufenden Positionen mehr
Vermögen: 35 359 $ am 31.03.2024
Profil
Paula A.
Cloghessy served as the Senior Vice President-Human Resources at Translate Bio, Inc. from 2017 to 2021.
Prior to that, she was the Vice President-Human Resources at Joule Unlimited Technologies, Inc. from 2010 to 2016.
In 2022, she will be the Chief People Officer & Executive Vice President at Seres Therapeutics, Inc. Ms. Cloghessy obtained her undergraduate degree from the University of Massachusetts.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SERES THERAPEUTICS INC
0,03% | 30.10.2023 | 45 684 ( 0,03% ) | 35 359 $ | 31.03.2024 |
Ehemalige bekannte Positionen von Paula Cloghessy
| Unternehmen | Position | Ende |
|---|---|---|
| SERES THERAPEUTICS, INC. | Human Resources Officer | 31.12.2023 |
| TRANSLATE BIO, INC. | Human Resources Officer | 14.09.2021 |
Joule Unlimited Technologies, Inc.
 Joule Unlimited Technologies, Inc. Industrial SpecialtiesProcess Industries Joule Unlimited Technologies, Inc. produces renewable fuels and chemicals. It offers a technology platform for liquid fuel from the Sun. The company was founded by Noubar B. Afeyan in 2007 and is headquartered in Bedford, MA. | Human Resources Officer | 01.04.2016 |
Ausbildung von Paula Cloghessy
| University of Massachusetts | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SERES THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Translate Bio, Inc.
 Translate Bio, Inc. BiotechnologyHealth Technology Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA. | Health Technology |
Joule Unlimited Technologies, Inc.
Joule Unlimited Technologies, Inc. Industrial SpecialtiesProcess Industries Joule Unlimited Technologies, Inc. produces renewable fuels and chemicals. It offers a technology platform for liquid fuel from the Sun. The company was founded by Noubar B. Afeyan in 2007 and is headquartered in Bedford, MA. | Process Industries |
